Science
Stopping SARS-CoV-2 in its tracks by blocking its main protease – Phys.org
Inasmuch as therapeutic options against coronavirus have been focused mainly on blocking the interaction between its spike protein and the ACE2 receptor on host…
Inasmuch as therapeutic options against coronavirus have been focused mainly on blocking the interaction between its spike protein and the ACE2 receptor on host cells, SARS-CoV-2 has several additional critical proteins that could potentially be targeted with drugs that have already been approved for use against other viruses. One of these viral proteins is the main protease (Mpro) that is needed to separate newly minted polypeptides into their functional component parts.
Scientists from the Department…
-
General23 hours agoBezos, Sanchez to exchange vows in star-studded Venice
-
General16 hours agoFallout from Ned Kelly’s last stand haunted families for generations
-
Business13 hours ago2 excellent ASX ETFs I think have great potential to beat the ASX 200
-
Noosa News17 hours agoMary Valley farmers mix it on the world stage